Correction to “Snail Controls the Mesenchymal Phenotype and Drives Erlotinib Resistance in Oral Epithelial and Head and Neck Squamous Cell Carcinoma Cells”(Otolaryngol–Head Neck Surg., (2012), 147, (726-732), 10.1177/0194599812446407);Snail controls the mesenchymal phenotype and drives erlotinib resistance in oral epithelial and head and neck squamous cell carcinoma cells

Otolaryngology - Head and Neck Surgery (United States)

Volumn 147, Issue 4, 2012, Pages 726-732

  Dennis, Miranda ^a   Wang, Guanyu ^a   Luo, Jie ^a   Lin, Yuan ^a   Dohadwala, Mariam ^a   Abemayor, Elliot ^a   Elashoff, David A ^a   Sharma, Sherven ^a,b   Dubinett, Steven M ^a,b   St John, Maie A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

E cadherin; epithelial mesenchymal transition (EMT); erlotinib; Snail

Indexed keywords

BETA CATENIN; ERLOTINIB; TRANSCRIPTION FACTOR SNAIL; UVOMORULIN;

ARTICLE; CARCINOMA CELL; CELL ASSAY; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSFECTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MOUTH MUCOSA; PHENOTYPE; PROTEIN EXPRESSION; SPHEROID CELL; TERTIARY HEALTH CARE; UNIVERSITY HOSPITAL; WESTERN BLOTTING; WOUND HEALING;

EID: 84870431949     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1002/ohn.815     Document Type: Erratum

References (14)

1. Ferlay J, Bray F, Pisani P, Parkin DM GLOBOCAN 2002 Cancer Incidence, Mortality and Prevalence Worldwide IARC CancerBase No. 5, Version 2.0. Lyon, France: IARC Press ; 2004 :
2. National Cancer Institute Surveillance Epidemiology and End Results. http://seer.cancer.gov/
3. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell. 2009 ; 139 (5). 871-890
4. St John MA, Dohadwala M, Luo J, et al. Proinflammatory mediators upregulate Snail in head and neck squamous cell carcinoma. Clin Cancer Res. 2009 ; 15 (19). 6018-6027
5. Anderson SN, Towne DL, Burns DJ, Warrior U. A high-throughput soft agar assay for identification of anticancer compound. J Biomol Screen. 2007 ; 12 (7). 938-945 (Pubitemid 47548592)
6. Lee GY, Kenny PA, Lee EH, Bissell MJ. Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007 ; 4 (4). 359-365 (Pubitemid 46766981)
7. Brembeck FH, Rosário M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev. 2006 ; 16 (1). 51-59 (Pubitemid 43089612)
8. Kenny PA, Lee GY, Myers CA, et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2007 ; 1 (1). 84-96 (Pubitemid 46776616)
9. Fukazawa H, Noguchi K, Masumi A, Murakami Y, Uehara Y. BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors. Mol Cancer Ther. 2004 ; 3: 1281-1288 (Pubitemid 39445336)
10. Du F, Nakamuria Y, Tan TL, et al. Expression of snail in epidermal keratinocytes promotes cutaneous inflammation and hyperplasia conductive to tumor formation. Cancer Res. 2010 ; 70 (24). 10080-10089
11. Mendelsohn AH, Lai CK, Shintaku IP, et al. Snail as a novel marker for regional metastasis in head and neck squamous cell carcinoma. Am J Otolaryngol. 2012 ; 33 (1). 6-13
12. Cano A, Pérez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000 ; 2 (2). 76-83
13. Dohadwala M, Yang SC, Luo J, et al. Cyclooxygenase-2-dependent regulation of E-cadherin: prostaglandin E(2) induces transcriptional repressors ZEB1 and snail in non-small cell lung cancer. Cancer Res. 2006 ; 66 (10). 5338-5345 (Pubitemid 43844959)
14. Yadav A, Kumar B, Datta J, Teknos TT, Kumar P. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway. Mol Cancer Res. 2011 ; 9 (12). 1658-1667